Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on DENTSPLY SIRONA (XRAY – Research Report), Pfizer (PFE – Research Report) and Enanta Pharmaceuticals (ENTA – Research Report). DENTSPLY SIRONA (XRAY) Robert W. Baird analyst Jeff Johnson maintained a Hold rating on DENTSPLY SIRONA on May 10 and set a price target of $41.00. The company's shares closed last Wednesday at $37.68, close to its 52-week low of $35.00. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-dentsply-sirona-xray-pfizer-pfe-and-enanta-pharmaceuticals-enta?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Jun 2022 até Jul 2022 Click aqui para mais gráficos DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Jul 2021 até Jul 2022 Click aqui para mais gráficos DENTSPLY SIRONA.